The frequency of grade I and II tumours was much higher among the non-BRCA1/2 group than in the unselected control group (odds ratio 1.8, P = 0.009) (Table 2) or in the BRCA1 and BRCA2 groups. This evidence concerns the gene BRCA2 and neoplasm.